Landsberg Bennett & Dubbaneh’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-4,285
| Closed | -$482K | – | 244 |
|
2020
Q3 | $482K | Buy |
4,285
+205
| +5% | +$23.1K | 0.08% | 142 |
|
2020
Q2 | $454K | Buy |
4,080
+662
| +19% | +$73.7K | 0.09% | 149 |
|
2020
Q1 | $309K | Buy |
+3,418
| New | +$309K | 0.09% | 131 |
|
2019
Q4 | – | Sell |
-4,757
| Closed | -$465K | – | 260 |
|
2019
Q3 | $465K | Sell |
4,757
-299
| -6% | -$29.2K | 0.13% | 145 |
|
2019
Q2 | $664K | Sell |
5,056
-1,357
| -21% | -$178K | 0.17% | 125 |
|
2019
Q1 | $898K | Buy |
+6,413
| New | +$898K | 0.21% | 112 |
|